Integrating smoking cessation support during lung cancer diagnostic workup: a pragmatic, multicenter, cluster-randomised controlled trial

Ingeborg Farver-Vestergaard*, Kaare Bro Wellnitz, Ole Hilberg, Morten Borg, Helle Marie Christensen, Uffe Bodtger, Niels Lyhne, Marie Lavesen, Maria Ralli, Anders Løkke

*Corresponding author af dette arbejde

Abstract

Background: Smoking cessation at or around the time of lung cancer diagnosis is associated with improved treatment outcomes, enhanced quality of life and increased survival. However, many patients continue smoking post-diagnosis. Aim: This study evaluated the effectiveness of a national initiative in Denmark that integrated smoking cessation support into the diagnostic workup for lung cancer within a pragmatic, multicenter, cluster-randomised controlled trial. Methods: Nine Danish hospitals were cluster-randomised to either the intervention group (integrated cessation support) or the control group (usual care). The intervention was implemented in five hospitals. Eighty-six patients (intervention = 39; control = 47) who were active smokers at referral completed questionnaires assessing smoking cessation initiation, motivation, quality of life and psychosocial consequences of diagnostic workup at baseline and 6-weeks follow-up. Logistic and multiple regression analyses were conducted. Additionally, 140 healthcare professionals completed a survey on cessation support practices pre-intervention, and 54 completed it post-intervention. Descriptive analyses were used to assess changes in clinical practice. Results: There were no statistically significant differences in smoking cessation initiation between the intervention and control groups (OR = 0.81 [0.41, 1.58], p = 0.53; adjusted OR = 0.79 [0.35, 1.79], p = 0.57). Among healthcare professionals in the intervention group, a larger proportion reported they “almost always” provided cessation after the implementation (35.1%) than before (18.3%). But the proportion who responded that they “almost never” provide support was also considerably larger after the implementation (13.5%) than before (3.2%). In the control group, proportions tended to shift more generally towards providing more support over time, and a considerably larger proportion reported to refer patients to external smoking cessation support at the follow-up measurement. Conclusion: The study was inconclusive, showing no significant effect of smoking cessation support during lung cancer diagnostic workup on patients' cessation initiation, possibly influenced by selection bias and varying intervention fidelity at study sites.

OriginalsprogEngelsk
Artikelnummer1696454
TidsskriftFrontiers in Health Services
Vol/bind5
ISSN2813-0146
DOI
StatusUdgivet - 2025

Fingeraftryk

Dyk ned i forskningsemnerne om 'Integrating smoking cessation support during lung cancer diagnostic workup: a pragmatic, multicenter, cluster-randomised controlled trial'. Sammen danner de et unikt fingeraftryk.

Citationsformater